Transcriptomics

Dataset Information

0

Francisella tularensis Schu4 gene expression during infection of mouse spleen


ABSTRACT: Francisella tularensis is classified as a Category A priority pathogen and causes fatal disseminated disease in humans upon inhalation of less than 50 bacteria. Although drugs are available for treatment, they are not ideal because of toxicity and delivery, and in some cases relapse upon withdrawal. We have an ongoing program in the development of novel FabI enoyl-ACP-reductase enzyme inhibitors for Francisella and other select agents. To establish ftFabI in F. tularensis as a clinically relevant drug target, we demonstrated that the enzyme is essential for growth in vitro and that ftfabI is not transcriptionally altered in the presence of exogenous fatty acids. Inhibition of ftFabI results in loss of viability that is not rescued by exogenous fatty acids supplementation. Importantly, whole-genome transcriptional profiling of F. tularensis with DNA microarrays from infected tissues revealed that ftfabI and de novo fatty acid biosynthetic genes are transcriptionally active during infection. This is the first demonstration that the FabI enoyl-ACP-reductase enzyme encoded by F. tularensis is essential and that de novo fatty acid biosynthetic components are transcriptionally active during infection in the mouse model tularemia.

ORGANISM(S): Francisella tularensis subsp. tularensis SCHU S4

PROVIDER: GSE39871 | GEO | 2012/08/04

SECONDARY ACCESSION(S): PRJNA171923

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2012-08-03 | E-GEOD-39871 | biostudies-arrayexpress
2010-05-26 | E-GEOD-5799 | biostudies-arrayexpress
2008-01-11 | GSE5799 | GEO
2015-07-30 | MODEL1507180003 | BioModels
2021-10-13 | GSE183001 | GEO
2008-08-13 | GSE12108 | GEO
2011-03-01 | GSE17248 | GEO
2011-03-01 | E-GEOD-17248 | biostudies-arrayexpress
2013-04-15 | GSE44320 | GEO
2010-11-29 | GSE23404 | GEO